Why Alianne Asset Management?
Alianne is a registered algorithmic/hybrid asset management company specializing in Foreign Exchange and Futures trading. We place priority on the security of clients' funds by having segregated accounts at renowned brokerage firms. We also provide great liquidity, transparency, and ultimate client control to our investors.
It is our sole objective to look for opportunities within inefficient markets. We leverage our proprietary technologies along with the skills of our management team to implement our algorithmic trading strategies 24 hours a day in liquid markets. We are your one stop shop for wealth management and asset protection.
The Benefits of Opening an Account with Alianne
- Account traded by our algorithmic systems and managed by professionals—Hybrid
- Opportunities in both rising and falling markets
- Uncorrelated returns to any owned stock, mutual-fund, and property investments
- Trading system follows our risk management principles
- Asset protection and portfolio diversification
- 24-hour web access to your private account
- You remain beneficial owner of your investment
Our servers are amongst the most reliable in the world running 24 hours a day with 99.999% uptime. Alianne uses algorithms to manage the entire trade cycle of its portfolio from the point of entry, to liquidation and therefore we need to be connected all the time. Our clients can rest well knowing that our technology is amongst the best and most reliable in the world, which truly enables them to Invest with Confidence.
Updated 2019-08-20 06:20:01 UTC
U.S. Steel to lay off up to 200 workers at Michigan plant: report
United States Steel Corp. will temporarily lay off up to 200 workers from a facility in Michigan, Reuters reported Monday. Citing filings dated Aug. 5, Reuters said production at the Great Lakes facility, near Detroit, would be halted, perhaps for more than six months. The steelworkers' union said layoffs were also expected at a U.S. Steel facility in Gary, Indiana, but the company said it "currently" does not expect layoffs there, Reuters reported. In a previous filing, U.S. Steel cited lower steel prices and weakening demand for idling plants. President Donald Trump has boasted about the strength of the American steel industry and how it has benefited from his administration's tariffs. U.S. Steel shares surged Monday, but are down 32% this year, compared to the S&P 500's 17% gain year to date.read more
Apple TV+ spending more than $6 billion on new shows, plans to launch before Disney+: report
Apple Inc. has committed to spending more than $6 billion on original content for its upcoming streaming-video service, which it expects to launch within two months, the Financial Times reported Monday. That would beat the launch of rival Disney+ from Walt Disney Co. , which is set to debut Nov. 12. Apple has not yet announced a price for its TV+ service, nor many other details, though a separate Bloomberg News report Monday said Apple is weighing a price of $9.99 a month, with a likely free trial period. The FT reported the first-year budget for TV+ has grown from $1 billion to more than $6 billion as it attempts to create a strong library of content to compete with a growing field of rivals. In comparison, streaming leader Netflix Inc. spent $13 billion on original content last year, and is expected to spend even more this year. The FT report said Apple is winning support in Hollywood with deals offering more money earlier in the production process.read more
Sarepta stock falls on FDA concerns about drug
Sarepta Therapeutics Inc. shares fell in the extended session Monday after the drug maker said the Food and Drug Administration raised concerns about its muscular dystrophy treatment. Sarepta shares fell 12% after hours, following a 3.7% decline in the regular session to close at $120.31. The FDA cited a risk of infections in the intravenous sites where the drug was administered and concerns about kidney toxicity. "We are very surprised to have received the complete response letter this afternoon," said Doug Ingram, Sarepta president and chief executive, in a statement. "Over the entire course of its review, the agency did not raise any issues suggesting the non-approvability of golodirsen, including the issues that formed the basis of the complete response letter." Sarepta said it was immediately requesting a meeting with the FDA to determine its next steps.read more
'Chinese Netflix' iQiyi passes 100 million subscribers, but stock plunges more than 10%
iQiyi Inc. , a streaming platform in China commonly compared with Netflix Inc. in the U.S., passed the 100-million-subscriber milestone in an earnings report released Monday, but shares fell more than 10% in late trading as financial results came in a bit lighter than expected. iQiyi reported a fiscal first-quarter net loss of 2.3 billion renminbi ($339 million), or RMB3.22 a share, on sales of RMB7.1 billion, roughly $1 billion in U.S. currency. Analysts on average expected the company to report a loss of 3.17 renminbi on revenue of RMB7.16 billion. Total number of subscribers was 100.5 million, up nearly 50% from 67.1 million a year ago with 98.9% paying for the service. The company also undershot analysts' expectations with its second-quarter forecast, guiding for revenue of 7.21 billion to 7.63 billion renminbi, while the average analyst forecast was for 7.98 billion renminbi, according to FactSet. U.S. ADS's for iQiyi closed with a 5.9% gain at $18.08, but fell lower than $16 in after-hours trading following the report.read more
Fabrinet stock plunges after earnings forecast comes in lower than expectations
Fabrinet shares dove in extended trading Monday after the fiber-optics company suggested its first-quarter performance will not live up to analysts' expectations. In a fiscal fourth-quarter earnings report, Fabrinet on Monday afternoon reported net income of $33 million, or 88 cents a share, on sales of $405.1 million, up from $345.3 million a year before. After adjusting for stock-based compensation and other effects, the company claimed earnings of $1 a share, up from 81 cents a share in the same quarter the prior year. Analysts on average expected adjusted earnings of 94 cents a share on sales of $400 million, according to FactSet. For the first quarter of its new fiscal year, though, Fabrinet guided for a sequential decline, with adjusted earnings of 80 cents to 84 cents a share on sales of $386 million to $394 million. Analysts on average were expecting adjusted earnings of 95 cents a share on sales of $407 million, according to FactSet. After closing with a 1.6% advance at $56.46, shares were selling for less than $50 a share in after-hours trading Monday.read more